Shulman A, Ghetler Y, Weiss E, Klein Z, Beyth Y, Ben-Nun I
In Vitro Fertilization Unit, Sapir Medical Center, Kfar Saba, Israel.
J Assist Reprod Genet. 1994 Mar;11(3):111-6. doi: 10.1007/BF02332087.
Corpus luteum steroidogenesis is lower for in vivo ectopic pregnancy than for intrauterine pregnancy. There is a progesterone hallmark level distinguishing between viable intrauterine pregnancy and nonviable or ectopic pregnancy. This study attempts to answer whether this is also true for in vitro fertilization-treated patients.
Using information retrieved from a computerized database, we compared the plasma 17 beta-estradiol (E2) and progesterone during the luteal phase and for every 2 to 3 days for several weeks during early pregnancy between those patients with proven ectopic pregnancies and those with singleton and multiple intrauterine pregnancies. Vaginal ultrasonography to detect an intrauterine gestational sac was performed from day 19. A total of 73 pregnancies resulted from the replacement of fresh embryos in our in vitro fertilization-embryo transfer program.
Only at day 10 post embryo transfer did those patients with ectopic pregnancy show statistically lower mean (SD) serum levels of E2 [2257 (SD, 2351) pmol/L] and plasma progesterone [PP; 221 (SD, 283) nmol/L] compared with patients with intrauterine pregnancy, whose mean E2 was 8846 (SD, 5871) pmol/L and mean PP was 805 (SD, 582) nmol/L (P = 0.008). For the rest of the follow-up until surgery was performed in ectopic pregnancy, there were no differences of statistical significance between extrauterine pregnancy and the intrauterine pregnancy groups. Furthermore, only on day 10 post embryo transfer, did we find a discriminatory zone (confidence interval, 95%) for E2 levels (903 to 3502 pmol/L for EP vs 6116 to 9493 pmol/L for a singleton and 4875 to 9493 pmol/L for multiple pregnancies). PP levels were 26 to 283 nmol/L for ectopic pregnancy versus 496 to 1096 nmol/L for both singleton and multiple pregnancies. An intrauterine gestational sac was visualized at a mean of 23.2 (SD, 4) days after embryo transfer. On this day, the mean P levels were 982.6 (SD, 286.2) nmol/L for intrauterine and 804.5 (SD, 502.4) nmol/L for ectopic pregnancies (P = NS).
Except for day 10 post embryo transfer, the steroidogenesis in ectopic pregnancy after in vitro fertilization treatment does not differ from successful intrauterine pregnancy. This observation negates an impaired steroidogenesis for ectopic pregnancy after in vitro fertilization and makes the PP level irrelevant in the diagnosis of pregnancy implantation.
与宫内妊娠相比,体内异位妊娠时黄体类固醇生成较低。存在一个孕酮标志性水平可区分存活的宫内妊娠与非存活或异位妊娠。本研究试图回答这在体外受精治疗的患者中是否同样如此。
利用从计算机数据库检索到的信息,我们比较了经证实为异位妊娠的患者与单胎及多胎宫内妊娠患者在黄体期以及妊娠早期数周内每2至3天的血浆17β-雌二醇(E2)和孕酮水平。从第19天开始进行经阴道超声检查以检测宫内妊娠囊。在我们的体外受精-胚胎移植项目中,共有73例妊娠是由新鲜胚胎移植所致。
仅在胚胎移植后第10天,异位妊娠患者的E2平均(标准差)血清水平[2257(标准差,2351)pmol/L]和血浆孕酮[PP;221(标准差,283)nmol/L]在统计学上低于宫内妊娠患者,后者的E2平均水平为8846(标准差,5871)pmol/L,平均PP为805(标准差,582)nmol/L(P = 0.008)。在异位妊娠手术前的其余随访期间,宫外妊娠组与宫内妊娠组之间无统计学显著差异。此外,仅在胚胎移植后第10天,我们发现了E2水平的一个鉴别区间(95%置信区间)(异位妊娠为903至3502 pmol/L,单胎妊娠为6116至9493 pmol/L,多胎妊娠为4875至9493 pmol/L)。异位妊娠的PP水平为26至283 nmol/L,而单胎和多胎妊娠均为496至1096 nmol/L。在胚胎移植后平均23.2(标准差,4)天可观察到宫内妊娠囊。在这一天,宫内妊娠的平均P水平为982.6(标准差,286.2)nmol/L,异位妊娠为804.5(标准差,502.4)nmol/L(P = 无显著差异)。
除胚胎移植后第10天外,体外受精治疗后异位妊娠的类固醇生成与成功的宫内妊娠无差异。这一观察结果否定了体外受精后异位妊娠存在类固醇生成受损的情况,并使得PP水平在妊娠着床诊断中无关紧要。